Patents by Inventor Krister Bamberg

Krister Bamberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapy employing LXRalpha modolators
    Publication number: 20080032961
    Abstract: The invention also relates to the use of active modulators of LXR? activity or expression in stimulation of pre-adipocyte differentiation and hence also in the treatment of insulin resistance syndrome, or dyslipidemia, or type 2 diabetes.
    Type: Application
    Filed: February 8, 2007
    Publication date: February 7, 2008
    Inventors: Krister Bamberg, Hilde Nebb
  • Guanidine and amidine acid derivatives and analogs and methods of using the same
    Publication number: 20070149614
    Abstract: The present invention relates to certain novel guanidine or amidine acid derivatives and analogs, to a process for preparing such compounds, having the utility in clinical conditions associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Application
    Filed: December 19, 2006
    Publication date: June 28, 2007
    Applicant: AstraZeneca AB
    Inventors: Krister Bamberg, Lanna Li
  • Guanidine and amidine acid derivatives and analogs and methods of using the same
    Patent number: 7169810
    Abstract: The present invention releates to certain novel guanidine or amidine acid derivatives and analogs, to a process for preparing such compounds, having the utility in clinical conditions associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: January 30, 2007
    Assignee: AstraZeneca AB
    Inventors: Krister Bamberg, Lanna Li
  • Compounds
    Publication number: 20040138300
    Abstract: The present invention releates to certain novel guanidine or amidine acid derivatives and analogs, to a process for preparing such compounds, having the utility in clinical conditions associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Application
    Filed: October 17, 2003
    Publication date: July 15, 2004
    Inventors: Krister Bamberg, Lanna Li
  • Therapy
    Publication number: 20040077613
    Abstract: The invention also relates to the use of active modulators of LXR&agr; activity or expression in stimulation of pre-adipocyte differentiation and hence also in the treatment of insulin resistance syndrome, or dyslipidemia, or type 2 diabetes.
    Type: Application
    Filed: November 10, 2003
    Publication date: April 22, 2004
    Inventors: Krister Bamberg, Hilde Nebb